Skip to main content
Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics

Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics

By Zeifmans LLP
Join Zeifmans Partner, Larry Zeifman, and weekly guest thought leaders in the psychedelics space, for a 6 part series, on exploring the business of psychedelics. New episode drops every Wednesday.

About Zeifmans:
Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, and is ranked as one of Canada’s top 20 firms by revenue.

Great ideas. Positive impact. That's Zeifmans.
Listen on
Where to listen
Apple Podcasts Logo

Apple Podcasts

Breaker Logo

Breaker

Google Podcasts Logo

Google Podcasts

Overcast Logo

Overcast

Pocket Casts Logo

Pocket Casts

RadioPublic Logo

RadioPublic

Spotify Logo

Spotify

Currently playing episode

Season 2 - Episode 4: Where do we go from here?

Micro-dosing with Zeifmans: Short podcasts on demystifying the business of psychedelics

1x
Season 2 - Episode 4: Where do we go from here?
Join out host, Larry Zeifman and this week's guests, Dr. Joseph Tucker, CEO of MagicMed Industries and Kelsey Ramsden, President & CEO of MINDCURE as they discuss the rapid growth of the psychedelic industry, predict future changes within the industry and changes required for psychedelics to become mainstream. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About MagicMed Industries MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.  MagicMed's molecular derivatives library, the PsybraryTM is anticipated to be an essential building block from which industry can develop new patented products.  The initial focus of the PsybraryTM is on psilocybin, which is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, Ibogaine, Mescaline, and Ayahuasca. About MINDCURE MINDCURE exists as a response to the current mental health crisis and urgent calls for effective treatments. MINDCURE believes in the need to reinvent the mental health care model for patients and practitioners to allow psychedelics to advance into common and accepted care. MINDCURE is focused on identifying and developing pathways and products that ease suffering, increase productivity, and enhance mental health. MINDCURE is interested in exploring diverse therapeutic areas beyond psychiatry, including digital therapeutics, neuro-supports, and psychedelics, all to improve mental health.
20:20
May 26, 2021
Season 2 - Episode 3: Financing: What investors are looking for and how to stand out
Join our host, Larry Zeifman and this week's guests, Henry Sant-Cassia, Founding-Partner of The Conscious Fund and Patrick Moher, CEO of Microdose Psychedelic Insights as they discuss Canadian psychedelic companies raising funds, financing for new entrants and why psychedelic companies are sought out by investors. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About The Conscious Fund The Conscious Fund invests in global early-stage ventures in psychedelic medicine, helping deliver better outcomes for mental health, addiction, and pain. About Microdose Psychedelic Insights  Microdose's vision is to distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry into the forefront of modern medicine.
20:21
May 19, 2021
Season 2 - Episode 2: Regulatory Issues: What's Important
Join our host, Larry Zeifman and this week's guests, David Wood, PhD, Partner at BLG and Spencer Hawkswell, CEO of Therapsil - together they discuss CDSA exemptions, Therapsil's work within the psychedelics industry and the future of regulations for psychedelics as medication for mental health treatment.   About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Borden Ladner Gervais LLP (BLG): As the largest, truly full-service Canadian law firm, Borden Ladner Gervais LLP (BLG) delivers practical legal advice for domestic and international clients across more practices and industries than any Canadian firm. With over 725 lawyers, intellectual property agents and other professionals, BLG serves the legal needs of businesses and institutions across Canada and beyond – from M&A and capital markets, to disputes, financing, and trademark & patent registration. About TheraPsil TheraPsil is a non-profit coalition dedicated to helping Canadians in medical need access legal, psilocybin-assisted psychotherapy to treat end-of-life distress. TheraPsil was formed in 2019 and is made up of healthcare professionals, patients, community members, and advocates. To meet our team, click here. After over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when it helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved 'section 56 exemptions' from the Minister of Health, on August 4th 2020. This was the first time section 56 exemptions for psilocybin had been approved for patients since psilocybin was made a controlled substance in 1974, in Canada. As of March 2021, TheraPsil has now supported 27 patients in 5 different provinces access legal, psilocybin-assisted psychotherapy.
16:31
May 12, 2021
Season 2 - Episode 1: What's happened since Season 1
Welcome back to Micro-dosing with Zeifmans - Season 2! Join our host, Larry Zeifman and this week's guests, Doug Drysdale, CEO of Cybin and Josh Bartch, Co-founder, Chairman & CEO of Mydecine Innovation Group, as they provide an industry update from where we left off at the end of season 1.  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Cybin Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. About Mydecine Innovation Group Mydecine Innovations Group™️ (NEO: MYCO) (OTC:MYCOF) (FSE:0NFA) is an emerging biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada.are (non-psychedelic) medicinal mushrooms. The mandate of this SAB continues to provide strategic guidance and direction for Mydecine’s clinical trials for PTSD, underpinned by pure data research, therapy, and scientific programs, advise on intellectual property; and, contribute commentary on Mydecine’s telehealth platform, Mindleap Health™. Mydecine has also successfully completed multiple acquisitions since its inception.
19:20
May 5, 2021
Welcome back to Micro-dosing with Zeifmans!
Welcome back to season 2 of Micro-dosing with Zeifmans: short podcasts on demystifying the business of Psychedelics! Join our host Zeifmans partner, Larry Zeifman, and weekly special guests, for the next 4 weeks as we continue to explore the industry of psychedelics together. Special guests this season include: Henri Sant – Cassia from The Conscious Fund, Dr. Joseph Tucker from MagicMed Industries, Doug Drydsale from Cybin, Spencer Hawkswell from Therapsil and Kelsey Ramsden from Mindcure. About Zeifmans: Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. Since 1959, Zeifmans has been developing innovative solutions driven by creative insight. Nearly 60 years later, our diverse local team has grown to over 150 team members, while our membership with Nexia International – one of the world’s top ten accounting and consulting networks – provides access to a global team of 3,400+ partners spanning more than 120 countries. Over 4,000 of our clients are private companies – many having been with us for more than a generation; proof that our connection with our clients remains a trusted long-term relationship based on the common goal of business growth and success. To learn more about our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.
01:27
April 28, 2021
BONUS – Reflecting on key themes and takeaways
On today's bonus episode of Micro-dosing with Zeifmans, our host Larry Zeifman reflects on key themes from our past 6 episodes, with special guests David Wood and Cameron MacDonald, both Partners at BLG and Dr. Joseph Tucker, CEO of MagicMed Industries Inc..  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About BLG As Canada’s law firm, BLG provides high-value advice and advocacy to address our clients’ business challenges and problems. We go beyond legal to anticipate, consult and advise in a rapidly changing digital world. We have extensive experience acting in specialized and complex deals and disputes. Vigilant, curious and collaborative, we harness technology and innovation to offer our clients exceptional service and value. About MagicMed Industries Inc.  MagicMed Industries Inc. ("MagicMed")  intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin, which is expected to be opportunistically expanded to other psychedelics like MDMA, ketamine, ibogaine, mescaline, and ayahuasca.
31:40
September 16, 2020
Episode 6: Psychedelics - What could go wrong…stock promoters, mostly prohibited compounds and global interest
On our final episode of Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's notable guest, Bruce Linton, Founder and former Chairman and Chief Executive Officer at Canopy Growth Corporation - together they discuss capital markets, his career, and what's next for the psychedelics industry.  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca.
15:55
September 9, 2020
Episode 5: Psychedelics 2.0: What will the future hold?
On today's episode of Micro-dosing with Zeifmans, we discuss "what's next" for the psychedelics industry.  Join our host, Larry Zeifman and this week's guests, Ronan Levy, Founder and Executive of Field Trip Health, and Susan Chapelle, Co-CEO of Havn Life, for Episode 5: Psychedelics 2.0. Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. Field Trip Health At Field Trip, we are redefining mental health and well-being through ground-breaking work in psychedelics and psychedelic-enhanced psychotherapy. With Field Trip Health centres opening across North America, and drug development and advanced research on plant-based psychedelics through Field Trip Discovery, we help people to heal and heighten engagement with the world. Havn Life Using a foundation of evidence-informed research Havn wants to empower people to connect to their potential and thrive.  Havn is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products. Havn Labs, a division of Havn, will support innovative therapies addressing human health through the development of methods for standardization and the extraction of quality-controlled compounds derived from plants and fungi.
23:00
September 2, 2020
Episode 4: Cannabis vs Psychedelics: A comparative view with the cannabis industry
On today's episode of Micro-dosing with Zeifmans, we compare the psychedelics industry with the cannabis industry and discuss where the similarities lie and what makes theses industries so vastly different. Join our host, Larry Zeifman and this week's guests, Danny Motyka, CEO of Psygen Labs, Daniel Cohen, CEO of Pharmadrug Inc. and Carl Saling, Founder, CEO and Director of Hollister Biosciences Inc. on Episode 4: Cannabis vs Psychedelics.  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Psygen Labs Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. About Pharmadrug Inc PharmaDrug Inc. is building an international controlled substance and natural medicine company with a focus on Europe. The Company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU. The Company also owns 100% of Super Smart, an early-stage retail company focused on consolidating the fragmented Dutch smartshop market. Smartshops are retail establishments in The Netherlands that specialize in the sale of psychoactive substances including psychedelic truffles. About Hollister Biosciences Inc.  Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.
16:53
August 26, 2020
Episode 3: “Going Public”: How to prepare and what you need to know
On today's episode of Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's guests, Anna Serin, Director of Listings at The Canadian Securities Exchange ("CSE") and Bill O’Hara, Managing Director, Institutional Equity Sales at Haywood Securities Inc.. Together they discuss what psychedelic companies need to do to prepare to go public, what investors are looking for and raising capital.  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About The CSE The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. About Haywood Securities: Haywood Securities is an investment firm that values its independence and its entrepreneurial spirit. Our analysts and advisors seek proven management in young companies that are built around fresh ideas with the potential for rapid growth in the energy, mining, technology and special situation sectors. Haywood offers these investment opportunities to a select group of qualified investors in both the institutional and retail markets.
17:06
August 19, 2020
Episode 2: Path to profitability: Governance, Regulation, Capital, and IP
On today's episode of Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's guests, Todd Shapiro, Co-founder, CEO and Director of Red Light Holland and Jeffery Merk, Partner at Aird & Berlis LLP  - together they examine the path to profitability in the psychedelics industry.  Have questions or want to learn more? Contact us direct at info@zeifmans.ca. About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Red Light Holland The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. About Aird & Berlis LLP We are proud to be one of Canada’s premier business law firms. At Aird & Berlis, we provide strategic legal and business advice in all principal areas of business law, including corporate finance, banking, insolvency and restructuring, energy, environmental, infrastructure/P3, technology and intellectual property, litigation, workplace law, municipal and land use planning, real estate and tax.
21:11
August 12, 2020
Episode 1: Defining the business of Psychedelics
On our first ever episode of, Micro-dosing with Zeifmans, our host, Larry Zeifman is joined by this week's guests, James Lanthier, CEO of Mindset Pharma Inc. and Henri-Sant Cassia, Founding-Partner of the Conscious Found - together they will begin to define the business of the psychedelics industry. Have questions or want to learn more? Contact us direct at info@zeifmans.ca.  About Zeifmans Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. For more on our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. About Mindset Pharma Inc.  Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders.  Founded by serial entrepreneurs and domain experts in drug development and medicinal chemistry and based in Toronto, Canada, Mindset is assembling a proprietary library of transformative psychedelic intellectual property designed to address chronic neuropsychiatric disorders efficiently and safely.  About The Conscious Fund The Conscious Fund invests in early stage ventures in plant based medicine.
18:03
August 5, 2020
Introducing: Micro-dosing with Zeifmans
Welcome to Micro-dosing with Zeifmans: short podcasts on demystifying the business of Psychedelics.  Join Zeifmans Partner, Larry Zeifman, on a  6-part episode journey,  as he explores the business of psychedelics, with weekly special guests, such as Todd Shapiro, Ronan Levy, Bruce Linton, Dr. Joe Tucker and other key thought leaders in the psychedelics space.  About Psychedelics:  Psychedelics include molecules like psilocybin (commonly referred to as magic mushrooms), ayahuasca, ketamine, LSD and MDMA (commonly referred to as ecstasy). The proposed applications of these mostly currently illegal substances, in the treatment of illnesses such as depression, anxiety, PTSD and traumatic brain injury, have recently shown very encouraging research results. These research findings are what is driving the growth of the industry on a global scale. Comparisons to the cannabis industry are natural, but there are clear distinctions that will be covered in the series. Canada’s position, as what Larry defines as the epicenter of cannabis finance, has facilitated Canada’s opportunity to play a key role in the psychedelics industry. About Zeifmans: Zeifmans is a full-service tax, accounting and consulting firm based in Toronto, Canada, ranked as one of Canada’s top 20 firms by revenue. Beyond the traditional offering, our services include business advisory, valuation, corporate finance, transaction services, corporate turnaround and insolvency, and estate and succession planning, supporting our 9,000+ clients through every step of the business life cycle. Since 1959, Zeifmans has been developing innovative solutions driven by creative insight. Nearly 60 years later, our diverse local team has grown to over 150 team members, while our membership with Nexia International – one of the world’s top ten accounting and consulting networks – provides access to a global team of 3,400+ partners spanning more than 120 countries. Over 4,000 of our clients are private companies – many having been with us for more than a generation; proof that our connection with our clients remains a trusted long-term relationship based on the common goal of business growth and success. To learn more about our services relating directly to the cannabis and psychedelics industry, visit zeifmans.ca. 
02:13
August 4, 2020